EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Profiling of sesquiterpenoid fractions from Artemisia annua L. and testing their in vitro anti-SARS-CoV-2 activity

Irma Gušić, Ilma Terzić, Toni Eterović, Adis Softić, Šejla Goletić, Teufik Goletić, Dejan Nikolić, Emina Korić, Katarina Bijelić, Haris Nikšić, Senka Vidović, Kemal Durić

Biomolecules and Biomedicine · 25.04.2025 · 25 (10) · 2345-2363

DOI: 10.17305/bb.2025.12052 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules and Biomedicine, online erschienen am 25.04.2025. Verfasst von Irma Gušić und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacognosy, Faculty of Pharmacy, University of Sarajevo, Sarajevo, Bosnia and Herzegovina. Hauptthemen laut MEDLINE: Artemisia annua, SARS-CoV-2, Antiviral Agents, Sesquiterpenes. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The current state of research on the anti‑SARS‑CoV‑2 potential of artemisinin‑related compounds has identified arteannuin B as a potent inhibitor of the nCoV‑2019BetaCov/Wuhan/WiV04/2019 and BetaCov/Italy/CDG1/2020 strains of the virus. The aim of this work was to fractionate the targeted sesquiterpenoid compounds, arteannuin B and artemisinin, from the complex matrix of the crude ethanolic leaf extract of Artemisia annua L. using high‑speed countercurrent chromatography (HSCCC) and to test the simplified or purified fractions against the genomically characterized Alpha SARS‑CoV‑2 variant in vitro. This is the first detailed in vitro anti‑SARS‑CoV‑2 study using an analytically characterized supercritical fluid extract of A. annua L. The preparative HSCCC method enabled the isolation of purified arteannuin B in a single chromatographic step, which was confirmed by LC‑ESI‑QTOF‑MS/MS. The MS data confirmed the selectivity of the HSCCC method for the targeted fractionation of artemisinin from the complex matrix, as it was successfully separated from the EtOH crude extract without co‑elution with arteannuin B. Antiviral activity determined by quantitative real‑time PCR (qRT‑PCR) yielded half‑maximal effective concentrations (EC₅₀) of 93.7 µg/mL (SC‑CO₂ extract), 173.5 µg/mL (EtOH extract), 187.3 µg/mL (artemisinin knockout fraction), 38.1 µg/mL (arteannuin B fraction), and >100 µg/mL (artemisinin). The arteannuin B fraction was highly active at 50 µg/mL (p < 0.0001) and 100 µg/mL (p < 0.0001), and inhibited the amplification of the SARS‑CoV‑2 N and RdRp genes by 84% and 100%, respectively. An important contribution of this study is the demonstration of the antiviral activity of arteannuin B against the Alpha variant of SARS‑CoV‑2, which is known to have increased infectivity and transmissibility.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Artemisia annuaSARS-CoV-2Antiviral AgentsSesquiterpenesPlant ExtractsHumansArtemisininsPlant LeavesAnimalsCOVID-19 Drug TreatmentVero CellsChlorocebus aethiops

Substanzen

Antiviral AgentsSesquiterpenesPlant ExtractsArtemisininsartemisinin

Autor:innen und Institutionen

  • Department of Pharmacognosy, Faculty of Pharmacy, University of Sarajevo, Sarajevo, Bosnia and Herzegovina.
  • Veterinary Faculty, University of Sarajevo, Sarajevo, Bosnia and Herzegovina.
  • Department of Pharmaceutical Sciences, Retzky College of Pharmacy, University of Illinois at Chicago, Chicago, Illinois, United States.
  • Department of Pharmacy, Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia; Center for Medical and Pharmaceutical Investigations and Quality Control, Faculty of Medicine, University of Novi Sad, Novi Sad, Ser…
  • Department of Pharmaceutical Engineering, Faculty of Technology Novi Sad, University of Novi Sad, Novi Sad, Serbia.

Zitieren

APA

Gušić, I., Terzić, I., Eterović, T., Softić, A., Goletić, Š., Goletić, T., Nikolić, D., Korić, E., Bijelić, K., Nikšić, H., Vidović, S., & Durić, K. (2025). Profiling of sesquiterpenoid fractions from Artemisia annua L. and testing their in vitro anti-SARS-CoV-2 activity. Biomolecules and Biomedicine, 25(10), 2345-2363. https://doi.org/10.17305/bb.2025.12052

Vancouver

Gušić I, Terzić I, Eterović T, Softić A, Goletić Š, Goletić T, et al. Profiling of sesquiterpenoid fractions from Artemisia annua L. and testing their in vitro anti-SARS-CoV-2 activity. Biomolecules and Biomedicine. 2025;25(10):2345-2363. doi:10.17305/bb.2025.12052

BibTeX
@article{Gui2025,
  author = {Gušić, Irma and Terzić, Ilma and Eterović, Toni and Softić, Adis and Goletić, Šejla and Goletić, Teufik and Nikolić, Dejan and Korić, Emina and Bijelić, Katarina and Nikšić, Haris and Vidović, Senka and Durić, Kemal},
  title = {Profiling of sesquiterpenoid fractions from Artemisia annua L. and testing their in vitro anti-SARS-CoV-2 activity},
  journal = {Biomolecules and Biomedicine},
  year = {2025},
  volume = {25},
  number = {10},
  pages = {2345--2363},
  doi = {10.17305/bb.2025.12052}
}
Kostenlos starten →